MYB and acute myeloid leukemia: To test this, we prioritized CEBPA, LYL1, SPI1, and RUNX1 as MYB-associated co-factors based on their physical interactions and functional dependencies in AML cells (Figure 7), and analyzed their chromatin dynamics in response to CRYBMIM treatment using ChIP-seq analysis.